New capacity helps eliminate bottleneck for COVID-19 vaccines
Opening a new facility, Biotage triples its production capacity for equipment crucial in the supply chain for the production of mRNA vaccines. Biotage is one of the few companies offering a complete solution and ready to go, off-the-shelf products for the purification of large scale lipids, used in mRNA vaccine development and production. Expanding its production capacity of large-scale flash columns by 300 per cent, Biotage is now helping pharmaceutical companies and contract manufacturers’ scale up lipid production for COVID-19 vaccines. A new, bespoke production facility is now